Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs

Oncogene

Volumn 27, Issue 3, 2008, Pages 264-273

  Morimoto, K ^a   Satoh Yamaguchi, K ^a   Hamaguchi, A ^a   Inoue, Y ^a   Takeuchi, M ^a   Okada, M ^a   Ikeda, W ^b   Takai, Y ^b   Imai, T ^a  

^a Kobe MI R and D Center ^*  (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer cell; CD226; Metastasis; Necl 5; Platelet; Poliovirus receptor

Indexed keywords

CD226 ANTIGEN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NECL 5 PROTEIN; NECTIN 2; POLIOVIRUS RECEPTOR; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL ADHESION; CELL GROWTH; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; LUNG BLOOD VESSEL; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BLOOD PLATELETS; CELL ADHESION MOLECULES; FEMALE; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; RECEPTORS, VIRUS;

MUS; ORYCTOLAGUS CUNICULUS; POLIOVIRUS;

EID: 38049132085     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210645     Document Type: Article

References (32)

1. Abercrombie M. (1979). Contact inhibition and malignancy. Nature 281: 259-262.
2. Abercrombie M, Heaysman JE. (1953). Observations on the social behaviour of cells in tissue culture. I. Speed of movement of chick heart fibroblasts in relation to their mutual contacts. Exp Cell Res 5: 111-131.
3. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B et al. (2003). Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226)activating molecule. J Exp Med 198: 557-567.
4. Chadeneau C, LeCabellec M, LeMoullac B, Meflah K, Denis MG. (1996). Over-expression of a novel member of the immunoglobulin superfamily in Min mouse intestinal adenomas. Int J Cancer 68: 817-821.
5. Chadeneau C, LeMoullac B, Denis MG. (1994). A novel member of the immunoglobulin gene superfamily expressed in rat carcinoma cell lines. J Biol Chem 269: 15601-15605.
6. Crissman JD, Hatfield JS, Menter DG, Sloane B, Honn KV. (1988). Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 48: 4065-4072.
7. Felding-Habermann B, Habermann R, Saldivar E, Ruggeri ZM. (1996). Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow. J Biol Chem 271: 5892-5900.
8. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M. (2004). CD96 (tactile)promote s NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol 172: 3994-3998.
9. Fujito T, Ikeda W, Kakunaga S, Minami Y, Kajita M, Sakamoto Y et al. (2005). Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3. J Cell Biol 171: 165-173.
10. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E. (2000). Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci USA 97: 6803-6808.
11. Guo W, Giancotti FG. (2004). Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826.
12. Hirota T, Irie K, Okamoto R, Ikeda W, Takai Y. (2005). Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEKERK-AP-1 pathway. Oncogene 24: 2229-2235.
13. Ikeda W, Kakunaga S, Itoh S, Shingai T, Takekuni K, Satoh K et al. (2003). Tage4/Nectin-like molecule-5 heterophilically trans-interacts with cell adhesion molecule nectin-3 and enhances cell migration. J Biol Chem 278: 28167-28172.
14. Ikeda W, Kakunaga S, Takekuni K, Shingai T, Satoh K, Morimoto K et al. (2004). Nectin-like molecule-5/Tage4 enhances cell migration in an integrin-dependent, nectin-3-independent manner. J Biol Chem 279: 18015-18025.
15. Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA et al. (2004). Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64: 8613-8619.
16. Kakunaga S, Ikeda W, Shingai T, Fujito T, Yamada A, Minami Y et al. (2004). Enhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD155 through the Ras-Raf-MEK-ERK signaling. J Biol Chem 279: 36419-36425.
17. Kato Y, Fujita N, Kunita A, Sato S, Kaneko M, Osawa M et al. (2003). Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J Biol Chem 278: 51599-51605.
18. Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N et al. (1990). The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 9: 3217-3224.
19. Kojima H, Kanada H, Shimizu S, Kasama E, Shibuya K, Nakauchi H et al. (2003). CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem 278: 36748-36753.
20. Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M. (2006). Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci 119: 4541-4553.
21. Masson D, Jarry A, Baury B, Blanchardie P, Laboisse C, Lustenberger P et al. (2001). Overexpression of the CD155 gene in human colorectal carcinoma. Gut 49: 236-240.
22. Mendelsohn CL, Wimmer E, Racaniello VR. (1989). Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56: 855-865.
23. Mueller S, Cao X, Welker R, Wimmer E. (2002). Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis. J Biol Chem 277: 7897-7904.
24. Nash GF, Turner LF, Scully MF, Kakkar AK. (2002). Platelets and cancer. Lancet Oncol 3: 425-430.
25. Reymond N, Imbert AM, Devilard E, Fabre S, Chabannon C, Xerri L et al. (2004). DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 199: 1331-1341.
26. Sherrington PD, Scott JL, Jin B, Simmons D, Dorahy DJ, Lloyd J et al. (1997). TLiSA1 (PTA1) activation antigen implicated in T cell differentiation and platelet activation is a member of the immunoglobulin superfamily exhibiting distinctive regulation of expression. J Biol Chem 272: 21735-21744.
27. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T et al. (1996). DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4: 573-581.
28. Shibuya K, Lanier LL, Phillips JH, Ochs HD, Shimizu K, Nakayama E et al. (1999). Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 11: 615-623.
29. Sloan KE, Eustace BK, Stewart JK, Zehetmeier C, Torella C, Simeone M et al. (2004). CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. BMC Cancer 4: 73.
30. Sloan KE, Stewart JK, Treloar AF, Matthews RT, Jay DG. (2005). CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics. Cancer Res 65: 10930-10937.
31. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W. (2003). Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer Sci 94: 655-667.
32. Thiery JP. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.